Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials

Janus kinase (JAK) inhibitors are promising treatments for atopic dermatitis (AD). The aim of this study was to assess the efficacy and safety of JAK inhibitors for AD treatment via the “Grading of Recommendations Assessment, Development, and Evaluation” approach. We identified 15 randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hou-Ren, Lu, Jing-Wun, Chen, Li-Yu, Chen, Tai-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067719/
https://www.ncbi.nlm.nih.gov/pubmed/33917069
http://dx.doi.org/10.3390/jpm11040279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067719/
https://www.ncbi.nlm.nih.gov/pubmed/33917069
http://dx.doi.org/10.3390/jpm11040279

Ejemplares similares